UCL Institute of Neurology National Hospital for Neurology & Neurosurgery Queen Square, London WC1N 3BG The Medical and Surgical Treatment of Epilepsy The Treatment of Epilepsy
The incidence and prevalence
Aetiologies and risk factors
Aims of treatment
Clinical settings
Principles of treatment Medical treatment Surgical treatment
Guidelines
Conclusions Incidence and Prevalence Incidence of new cases of epilepsy: 50/100,000/year
Incidence of single seizures: 20 - 30/100,000/year
Prevalence of active epilepsy 5 - 10/1,000 (50% because on AEDs) Severe epilepsy: 1 - 2/1,000
72 000 - 80 000 cases of severe epilepsy Incidence and Prevalence in the UK
GP 1 - 2 new cases of epilepsy/year 10 - 12 cases of active epilepsy
Neurologist 150 cases of epilepsy/single seizures/year 1,200 cases of active epilepsy
Epilepsy: Aetiologies and Risk Factors Risk factors varies with age and geographic location
Congenital, developmental and genetic conditions in childhood, adolescence and young adults
Head trauma, infection and tumours at any age although tumours more likely over age 40
Cerebrovascular disease common in elderly
Endemic infections are associated with epilepsy in certain areas malaria, neurocysticercosis, paragonomiasis, no adequate large scale study of attributable risk yet
Antiepileptic Treatment AEDs are mainstay treatment
Non-pharmacological options feasible in only few selected cases Surgery Curative Palliative Ketogenic diet (children) Behaviour modification Avoidance therapy in cases with clear precipitants
Aims of Antiepileptic Treatment Complete seizure freedom 50% seizure reduction of little benefit
No adverse effects long term treatment - long term effects ? cognitive effects debilitating teratogenicity
Non-obtrusive treatment once or twice daily No PK or PD interactions
Maintenance of a normal lifestyle
Reduction in morbidity and mortality AED Treatment: Clinical Settings Prophylactic Treatment
Newly Diagnosed Epilepsy Single seizure Recurrent seizures
Chronic Epilepsy
Prophylactic use of AEDs Often advocated after Head injury Craniotomy
There are considerable compliance problems
There is no evidence of a protective effect of this policy No place for this! Better wait for the event to happen
Is it Epilepsy ? Newly diagnosed or suspected cases at Primary Care level > 50% not epilepsy commonest differential diagnosis: syncope Chronic cases 15 - 20% not epilepsy mostly psychological in nature
Careful diagnostic assessment a must in all cases
The Single Seizure A controversial area!
Single unprovoked attack usually not treated: practice to defer treatment until 2 or more seizures, although patients at high risk may be treated after a first attack
Incidence of epilepsy much greater than of single seizures
Community-based studies show that overall risk of a second seizure greater than previously accepted selection bias Patients Seizure type time to entry bias
The Single Seizure AED treatment following a single seizure reduce risk of recurrence in the short term although long term prognosis not changed
This may eventually lead to changes in the way single seizures are managed treatment after first seizure - for six months, for a year? tailored treatment and not symptomatic
Meanwhile, involve patient and or guardians in the decision Recurrent Seizures Treatment recommended after two or more seizures
Exceptions: - Long interval between seizures - Clear identifiable precipitant factor - Patient against treatment - Unlikely compliance Precipitating Factors Fever Drugs Alcohol Photo-Sensitivity Sleep Deprivation Reflex Mechanisms Acute Metabolic Stress Emotional Stress/Major Life Events
Starting an AED Starting AED treatment is a major event and should not be undertaken without careful evaluation of all relevant factors
Therapy is a long term prospect
All implications must be fully explained to the individual and or guardian
Paramount that the patient or guardians are kept informed about the treatment process and the rationale behind it
Starting Treatment Treatment should always be started with a single drug at a small dose
All common side-effects must be discussed teratogenicity and contraception if applicable
Importance of compliance should be stressed
Careful titration is a must - start low, go slow
Choice of AEDs treatment
Choice of AED influenced by: Type of seizure and or epileptic syndrome Individual circumstances of patient Side effect profile of drug Personal preferences
No clear cut evidence based medicine is available!
Clinical practice is based more on dogmatic teaching than on scientific knowledge
Empirical rather than rational
Principles of AED treatment Diagnosis clearly established
Appropriate first line drug for syndrome and patient
One drug at a time as a rule: If first drug ineffective add another first line drug and then withdraw first drug
Combination therapy only when single drug ineffective What Is Chronic Epilepsy ?
Active 2 years after onset
Failed 2 first line AEDs
Great number of seizure in early history
Chronic Epilepsy 1 Review history of epilepsy - Obtain and review old notes if possible - Interview patient and witness - Classify seizures
Review past and present AED treatment for efficacy and side-effects
Chronic Epilepsy 2 Select the AED that is most likely to be efficacious and with the least side-effects
Adjust the dose of the selected drug to the optimum
Attempt to reduce and taper other AEDs
If seizures continue despite a maximally tolerated dose of a first-line drug: - Check compliance - tablet count, serum levels, counselling
Commence another first-line AED if there is one that has not been used to its optimum
Chronic Epilepsy 3 If seizures continue try a combination of two AEDs
If combination unhelpful, AED which appears most effective and with fewer side-effects should be continued and the other AED replaced
If this drug is effective, withdrawal of the initial agent should be considered; if not, it should be replaced by another AED
Consider the possibility of surgical treatment
Consider using an experimental AED
Inappropriate use of AEDs Inappropriate treatment of people who do not have epilepsy
Inappropriate drug treatment of patients who do have epilepsy JME easily treated with some AEDs but poorly controlled with others Partial epilepsies often misdiagnosed as generalised epilepsy
Incorrect dosages or inappropriate use of polytherapy Overzealous adherance to therapeutic AED drug levels
AED drug levels monitoring
Measurement of AED levels: drug toxicity occurs and needs to be documented suspected non-compliance suspected drug interactions during pregnancy (free levels) during systemic illness phenytoin therapy
Not a guide to dosing!
Partial seizures: simple, complex, sec gen. Stereotyped onset No non-epileptic attacks No contraindication for Neurosurgery Active epilepsy for >2-3 yr, despite 3 + AEDs Inadequate seizure control: > 1-2 c p s /month Acceptance of best risk / benefit ratio
Who Should be Evaluated for Surgery Best risk vs benefit ratio of temporal lobe epilepsy surgery Medical Surgical
10% Palliative Procedures Hemispherectomy Corpus callosotomy Subpial transection Vagal Nerve Stimulation Range of Epilepsy Surgery Convergence of data One epileptogenic & dysfunctional area Rest of brain normal Clinical Neuro-Imaging EEG Neuropsychology Neuropsychiatry Psychosocial Components of Presurgical Evaluation Realistic expectations? Improvement in life from seizure control? Intelligence, memory will not improve Not more attractive, employable Need to continue AEDs after
Social support Family, friends, community, finances
Psychosocial
Fundamental MRI predicts nature and extent of pathology Unusual to resect area with normal imaging Poor results if imaging normal Neuro-imaging TLE: Anterior Temporal Lobe resection Focal pathology: 70% seizure free, 25% >90% reduced DNT, cavernoma>HS>AVM>trauma>MCD 20% seizure free if no focal pathology
Extra Temporal Lobe Focal pathology: 60% seizure free, 20% >90% reduced DNT, cavernoma, glioma>AVM>trauma MCD 20-30% seizure free, if focal
<20% seizure free if no focal pathology
Pathology and Outcome Treatment Guidelines for Epilepsy NICE = www.nice.org.uk National Institute for Clinical Excellence (England and Wales)
AAN = www.aan.com American Academy of Neurology (USA) Primary Care Guidelines for Epilepsy Referral of ALL who experience a suspected seizure Seen within 14 days by specialist Risk and safety precautions documented Care Plan in place At least a yearly review Early re-referral if Treatment failure Seizures not controlled Diagnostic uncertainty Considering pregnancy Considering drug withdrawal
Managing People With Epilepsy Holistic issues: - Interest and continuity of care - Clear plan - Information provision - SUDEP - Easy access